3 min readStem Cells and Nanofibres Could Lead to Treatments for Neurological Diseases
Ann Arbor, MI – Every week in his clinic at the University of Michigan, neurologist Dr. Joseph Corey, treats patients whose nerves are dying or shrinking due to disease or injury.
He sees the pain, the loss of ability and the other effects that nerve-destroying conditions cause – and wishes he could give patients more effective treatments than what’s available, or regenerate their nerves. Then he heads to his research lab at the VA Ann Arbor Healthcare System, where his team is working toward that exact goal.
In new research published in several recent papers, Corey and his colleagues from the U-M Medical School, VAAAHS and the University of California, San Francisco report success in developing polymer nanofibre technologies for understanding how nerves form, why they don’t reconnect after injury, and what can be done to prevent or slow damage.
Using polymer nanofibres thinner than human hairs as scaffolds, researchers coaxed a particular type of brain cell to wrap around nanofibres that mimic the shape and size of nerves found in the body.
They’ve even managed to encourage the process of myelination – the formation of a protective coating that guards larger nerve fibres from damage. They began to see multiple concentric layers of the protective substance called myelin start to form, just as they do in the body. Together with the laboratory team of their collaborator Jonah Chan at UCSF, the authors reported the findings in Nature Methods.
The research involves oligodendrocytes, which are the supporting actors to neurons — the “stars” of the central nervous system. Without oligodendrocytes, central nervous system neurons can’t effectively transmit the electrical signals that control everything from muscle movement to brain function.
Oligodendrocytes are the type of cells typically affected by multiple sclerosis, and loss of myelin is a hallmark of that debilitating disease.
The researchers have also determined the optimum diameter for the nanofibres to support this process – giving important new clues to answer the question of why some nerves are myelinated and some aren’t.
While they haven’t yet created fully functioning “nerves in a dish,” the researchers believe their work offers a new way to study nerves and test treatment possibilities. Corey, an assistant professor of neurology and biomedical engineering at the U-M Medical School and researcher in the VA Geriatrics Research, Education and Clinical Center, explains that the thin fibres are crucial for the success of the work.
“If it’s about the same length and diameter as a neuron, the nerve cells follow it and their shape and location conform to it,” he says. “Essentially, these fibres are the same size as a neuron.”
The researchers used polystyrene, a common plastic, to make fibres through a technique called electrospinnning. In a recent paper in Materials Science and Engineering C, they discovered new techniques to optimize how fibres made from poly-L-lactide, a biodegradable polymer, can be better aligned to resemble neurons and to guide regenerating nerve cells.
They’re also working to determine the factors that make oligodendrocytes attach to the long narrow axons of neurons, and perhaps to start forming myelin sheaths too.
By attaching particular molecules to the nanofibres, Corey and his colleagues hope to learn more about what makes this process work — and what makes it go awry, as in diseases caused by poor nerve development.
“What we need to do for multiple sclerosis is to encourage nerves to remyelinate,” he says. “For nerve damage caused by trauma, on the other hand, we need to encourage regeneration.”
In addition to Corey, the research has been led by Chan, the Rachleff Professor of Neurology at UCSF, VAAAHS lab team member and U-M graduate Samuel J. Tuck, U-M biomedical engineering graduate student Michelle Leach, UCSF’s Stephanie Redmond, Seonook Lee, Synthia Mellon and S.Y. Christin Chong, and Zhang-Qi Feng of U-M Biomedical Engineering.
Peripheral nerves, which have neurons at the centre surrounded by cells called Schwann cells, can also be studied using the nanofibre technique. The system could also be used to study how different types of cells interact during and after nerve formation.
Toward creating new nerves, Corey’s lab has collaborated with R. Keith Duncan, PhD, Associate Professor of Otolaryngology. Published in Biomacromolecules, they found that stem cells are more likely to develop into neurons when they are grown on aligned nanofibres produced in Corey’s lab. They eventually hope to use this approach to build new nerves from stem cells and direct their connections to undamaged parts of the brain and to muscle.
Eventually, Corey envisions, perhaps nerves could be grown along nanofibres in a lab setting and then transferred to patients’ bodies, where the fibre would safely degrade.